IT8522214A0 - Esapeptidi ad attivita' ipotensiva. - Google Patents

Esapeptidi ad attivita' ipotensiva.

Info

Publication number
IT8522214A0
IT8522214A0 IT8522214A IT2221485A IT8522214A0 IT 8522214 A0 IT8522214 A0 IT 8522214A0 IT 8522214 A IT8522214 A IT 8522214A IT 2221485 A IT2221485 A IT 2221485A IT 8522214 A0 IT8522214 A0 IT 8522214A0
Authority
IT
Italy
Prior art keywords
hexapeptides
hypotensive activity
hypotensive
activity
Prior art date
Application number
IT8522214A
Other languages
English (en)
Other versions
IT1190389B (it
Inventor
Fabio Bonelli
Antonello Pessi
Antonio Silvio Verdini
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Priority to IT22214/85A priority Critical patent/IT1190389B/it
Publication of IT8522214A0 publication Critical patent/IT8522214A0/it
Priority to US06/893,146 priority patent/US4732890A/en
Priority to JP61208104A priority patent/JPS6270396A/ja
Priority to EP86112387A priority patent/EP0215410A3/en
Application granted granted Critical
Publication of IT1190389B publication Critical patent/IT1190389B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT22214/85A 1985-09-19 1985-09-19 Esapeptidi ad attivita' ipotensiva IT1190389B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT22214/85A IT1190389B (it) 1985-09-19 1985-09-19 Esapeptidi ad attivita' ipotensiva
US06/893,146 US4732890A (en) 1985-09-19 1986-08-05 Retro-inverso hexapeptide neurotensin analogs, process for their preparation and pharmaceutical compositions containing them
JP61208104A JPS6270396A (ja) 1985-09-19 1986-09-05 ｒｅｔｒｏ逆転ヘキサペプチドニユ−ロテンシン類似体
EP86112387A EP0215410A3 (en) 1985-09-19 1986-09-08 Retro-inverso hexapeptide neurotensin analogs, process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22214/85A IT1190389B (it) 1985-09-19 1985-09-19 Esapeptidi ad attivita' ipotensiva

Publications (2)

Publication Number Publication Date
IT8522214A0 true IT8522214A0 (it) 1985-09-19
IT1190389B IT1190389B (it) 1988-02-16

Family

ID=11193147

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22214/85A IT1190389B (it) 1985-09-19 1985-09-19 Esapeptidi ad attivita' ipotensiva

Country Status (4)

Country Link
US (1) US4732890A (it)
EP (1) EP0215410A3 (it)
JP (1) JPS6270396A (it)
IT (1) IT1190389B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
IT1228451B (it) * 1989-02-22 1991-06-19 Sclavo S P A Siena Nuovi derivati diamminici geminali e loro impiego nelle sintesi di peptidi retro-inversi
US5767236A (en) * 1990-05-09 1998-06-16 Biomeasure, Inc. Linear therapeutic peptides
US5393740A (en) * 1991-07-30 1995-02-28 Tsumura & Co. Neurotensin Hexapeptides
US5374621A (en) * 1991-09-13 1994-12-20 Regents Of The University Of California Neurotensin method for inhibiting vascular leakage
US6458357B1 (en) 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides
DK1400551T3 (da) * 1998-08-28 2007-10-15 Amylin Pharmaceuticals Inc Polyamidkæder med præcis længde og deres konjugater med proteiner
US8183339B1 (en) 1999-10-12 2012-05-22 Xigen S.A. Cell-permeable peptide inhibitors of the JNK signal transduction pathway
US6610820B1 (en) * 1999-10-12 2003-08-26 University Of Lausanne Cell-permeable peptide inhibitors of the JNK signal transduction pathway
US20040082509A1 (en) 1999-10-12 2004-04-29 Christophe Bonny Cell-permeable peptide inhibitors of the JNK signal transduction pathway
US20050119454A1 (en) * 2000-01-24 2005-06-02 The Cielo Institute, Inc. Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
US6560542B1 (en) * 2000-01-24 2003-05-06 The Cielo Institute Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
US6865492B2 (en) * 2000-01-24 2005-03-08 The Cielo Institute, Inc. Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
WO2007031098A1 (en) 2005-09-12 2007-03-22 Xigen S.A. Cell-permeable peptide inhibitors of the jnk signal transduction pathway
US8080517B2 (en) * 2005-09-12 2011-12-20 Xigen Sa Cell-permeable peptide inhibitors of the JNK signal transduction pathway
EP2276479B1 (en) * 2008-04-15 2014-07-02 SineVir Therapeutics LLC Prodrugs of neuraminidase inhibitors
WO2009143864A1 (en) * 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
WO2009143865A1 (en) * 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
WO2010072228A1 (en) 2008-12-22 2010-07-01 Xigen S.A. Novel transporter constructs and transporter cargo conjugate molecules
JP5457813B2 (ja) * 2009-12-16 2014-04-02 ルネサスエレクトロニクス株式会社 Ａｄｐｌｌ回路、半導体装置及び携帯情報機器
WO2011160653A1 (en) 2010-06-21 2011-12-29 Xigen S.A. Novel jnk inhibitor molecules
JP5857056B2 (ja) 2010-10-14 2016-02-10 ザイジェン インフラメーション エルティーディー 慢性又は非慢性の炎症性眼疾患を治療するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
WO2013091670A1 (en) 2011-12-21 2013-06-27 Xigen S.A. Novel jnk inhibitor molecules for treatment of various diseases
WO2015197097A1 (en) 2014-06-26 2015-12-30 Xigen Inflammation Ltd. New use for jnk inhibitor molecules for treatment of various diseases
WO2014206427A1 (en) 2013-06-26 2014-12-31 Xigen Inflammation Ltd. New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
CA2903275A1 (en) 2013-06-26 2014-12-31 Xigen Inflammation Ltd. New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929756A (en) * 1973-11-21 1975-12-30 Univ Brandeis Synthetically produced tridecapeptide having the same activity as the hypothalamic substance, neurotensin
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
IT1190891B (it) * 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
IT1164225B (it) * 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
IT1164240B (it) * 1983-05-25 1987-04-08 Anic Spa Decapeptide parzialmente retro-invertito inibitore specifico della renina con elevata resistenza alla idrolisi enzimatica
IT1164239B (it) * 1983-05-25 1987-04-08 Anic Spa Un retro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica
IT1206339B (it) * 1984-01-13 1989-04-14 Anic Spa Analoghi retro-invertiti esapeptidici c-terminali della sostanza p.
IT1178786B (it) * 1984-12-21 1987-09-16 Assorenti Analoghi retro-inverso parzialmente modificati della neurotensina

Also Published As

Publication number Publication date
EP0215410A3 (en) 1989-07-05
EP0215410A2 (en) 1987-03-25
JPS6270396A (ja) 1987-03-31
IT1190389B (it) 1988-02-16
US4732890A (en) 1988-03-22

Similar Documents

Publication Publication Date Title
IT8522214A0 (it) Esapeptidi ad attivita' ipotensiva.
IT8423173A0 (it) Dipeptidi ad attivita'farmacologica.
FI861210A0 (fi) N,n'-dialkylguanidinodipeptider.
IT8520973A0 (it) Benzoil-uree ad attivita'insetticida.
NO862970D0 (no) 3-propenylcephalosporinsolvater.
IT1187756B (it) Isoindolinil-alchil-piperazine ad attivita' farmaceutica
IT8721063A0 (it) Composizione ad attivita'tricogena.
IT1208512B (it) Benzoil-uree ad attivita'insetticida.
NO863638L (no) Oktapeptid.
FI854730A0 (fi) Vattentorn 2000.
IT8521042A0 (it) Composti tripeptidici ad azione ipotensiva.
IT8621194A0 (it) Azolilderivati ad attivita'antifungina.
IT8620026A0 (it) Tripeptide ad attivita'immunostimolante.
DE3684900D1 (de) 2,2'-bi-1h-imidazole.
DK212786D0 (da) 1,3-dioxanethere
IT8620027A0 (it) Tripeptide ad attivita'immunostimolante.
IT8522424A0 (it) Composto ad attivita'pilostimolante.
IT8419682A0 (it) Composti ad attivita'ipolipemizzante.
IT8419683A0 (it) Composti ad attivita'ipolipemizzante.
IT8522705A0 (it) Azolilderivati ad attivita'antufungina.
IT1190646B (it) 2,4-dicloro-5-nitro-tiazolo
IT8419819A0 (it) Azetidin-2-oni con attivita'antimicotica.
IT8821431A0 (it) Composti ad attivita' fungicida.
IT8422702A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini 2,2-disostituiti ad attivita'ipotensiva.
IT207187Z2 (it) Struttura di suola a flessibilita'differenziata.